These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8317345)

  • 1. [Prostaglandins as ocular hypotensive drugs].
    Matsuo T
    Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):289-96. PubMed ID: 8317345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of prostaglandins on uveoscleral outflow.
    Schachtschabel U; Lindsey JD; Weinreb RN
    Curr Opin Ophthalmol; 2000 Apr; 11(2):112-5. PubMed ID: 10848216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostaglandins on the aqueous humor outflow pathways.
    Weinreb RN; Toris CB; Gabelt BT; Lindsey JD; Kaufman PL
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S53-64. PubMed ID: 12204701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uveoscleral outflow routes.
    Nilsson SF
    Eye (Lond); 1997; 11 ( Pt 2)():149-54. PubMed ID: 9349404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
    Chen J; Woodward DF
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha.
    Crawford K; Kaufman PL
    Arch Ophthalmol; 1987 Aug; 105(8):1112-6. PubMed ID: 3477218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveoscleral outflow--a review.
    Alm A; Nilsson SF
    Exp Eye Res; 2009 Apr; 88(4):760-8. PubMed ID: 19150349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins. Old concepts and new perspectives.
    Bito LZ
    Arch Ophthalmol; 1987 Aug; 105(8):1036-9. PubMed ID: 3115238
    [No Abstract]   [Full Text] [Related]  

  • 9. The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle.
    Matsuo T; Cynader MS
    Br J Ophthalmol; 1993 Feb; 77(2):110-4. PubMed ID: 8435410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
    Yousufzai SY; Ye Z; Abdel-Latif AA
    Exp Eye Res; 1996 Sep; 63(3):305-10. PubMed ID: 8943703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
    Krauss AH; Wiederholt M; Sturm A; Woodward DF
    Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.
    Takagi Y; Nakajima T; Shimazaki A; Kageyama M; Matsugi T; Matsumura Y; Gabelt BT; Kaufman PL; Hara H
    Exp Eye Res; 2004 Apr; 78(4):767-76. PubMed ID: 15037111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prostaglandin F2 alpha-1-isopropylester (PGF2 alpha-IE) on uveoscleral outflow.
    Nilsson SF; Sperber GO; Bill A
    Prog Clin Biol Res; 1989; 312():429-36. PubMed ID: 2678148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of prostaglandin E receptor subtypes in the ciliary body of mouse eye.
    Takamatsu M; Hotehama Y; Goh Y; Mishima HK
    Exp Eye Res; 2000 May; 70(5):623-8. PubMed ID: 10870520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow.
    Lindsey JD; Kashiwagi K; Kashiwagi F; Weinreb RN
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S53-9. PubMed ID: 9154277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of ocular response to topical and systemic prostaglandin.
    Green K; Kim K
    Invest Ophthalmol; 1975 Jan; 14(1):36-40. PubMed ID: 1110134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice.
    Ota T; Aihara M; Saeki T; Narumiya S; Araie M
    Br J Ophthalmol; 2007 May; 91(5):673-6. PubMed ID: 17124244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction systems for prostaglandins in the iris and ciliary body.
    Mittag TW
    Prog Clin Biol Res; 1989; 312():139-48. PubMed ID: 2678140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sections.
    Sharif NA; Davis TL; Williams GW
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):121-32. PubMed ID: 15857278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.